| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $269K | -10.3% |
| Cost of Revenue | $1.9M | +48.3% |
| R&D Expense | $4.6M | -69.9% |
| SG&A Expense | $7.0M | -39.5% |
| Operating Income | -$62.5M | -123.6% |
| Pre-tax Income | -$76.9M | -110.2% |
| Income Tax | $0 | — |
| Net Income | -$53.8M | -46.9% |
| EPS (Basic) | -$3.38 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.6M | +1388.5% |
| Accounts Receivable | $35K | -50.7% |
| Inventory | $2.6M | -22.8% |
| Current Assets | $25.3M | +388.9% |
| Total Assets | $48.4M | +609.9% |
| Current Liabilities | $7.8M | -83.5% |
| Long-term Debt | $16.1M | -58.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | +47.5% |
| Capital Expenditures | $1.3M | +284.4% |
| Investing Cash Flow | -$1.3M | -276.5% |
| Financing Cash Flow | $21.9M | +0.0% |
| Free Cash Flow | -$14.7M | +43.2% |
| +93.0% |
| EPS (Diluted) | -$3.70 | +92.3% |
| Total Liabilities |
| $28.5M |
| — |
| Stockholders' Equity | $19.9M | — |